15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering CLARIVATE PLC, 0 rate it Buy or better, 4 sit at Hold, and 2 rate it Sell or worse, a moderate sell consensus. Targets are tightly clustered, $2.50 to $3.00, so the covering firms are broadly aligned. The average target of $2.77 sits 15% above the current $2.42. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.17 next quarter toward $0.74 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Sell
Strong Buy00%
Buy00%
Hold467%
Sell233%
Strong Sell00%
Based on 6 analysts giving stock ratings to CLARIVATE PLC.
As of Jul, 0 of 6 firms rate CLVT a Buy (4 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
CLVT EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.17 – $0.17 · 2 analysts · -6% YoY
Next period, 2 analysts expect CLARIVATE PLC to earn $0.17 a share (range $0.17 – $0.17), versus $0.18 a year earlier. Full-year consensus is $0.73, growing to $0.74 the year after.
REVENUE · NEXT QUARTER
$496.4M
Range $496.4M – $496.4M · 2 analysts · -20% YoY
Revenue is expected to reach $496.4M (range $496.4M – $496.4M), -20.3% year-over-year. Full-year consensus is $2.2B, rising to $2.0B next year.
Top analysts covering CLARIVATE PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLVT.
#1
Manav Patnaik
Barclays · Rank #113
Sell
$2.50+3.5% to target
Overall win rate
41%
+ Follow
#2
George Tong
Goldman Sachs · Rank #293
Hold
$3.10+28.4% to target
Overall win rate
33%
+ Follow
#3
Ashish Sabadra
RBC Capital
Hold
$3.00+24.2% to target
Coverage
—
+ Follow
#4
Peter Christiansen
Citigroup
Hold
$2.80+15.9% to target
Coverage
—
+ Follow
#5
Shlomo Rosenbaum
Stifel
Buy
$6.00+148.4% to target
Coverage
—
+ Follow
CLVT stock forecast FAQ
What is CLVT's average 12-month price target?+
The 3 analysts with a live target average $2.77 for CLARIVATE PLC over the next 12 months, ranging from a $3.00 high to a $2.50 low.
Is CLVT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Sell. Of the 6 analyst ratings, 0 are Buy or Strong Buy, 4 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for CLVT?+
The Street-high target is $3.00 (RBC Capital), and the Street-low is $2.50 (Barclays). The average of all 3 active targets is $2.77.
How many Wall Street analysts cover CLVT?+
6 analysts have an active rating on CLARIVATE PLC, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering CLVT?+
Among analysts who currently cover CLVT, Manav Patnaik of Barclays has the strongest overall Quantellect track record (Rank #113). Their current call is Sell with a $2.50 target.
What is CLARIVATE PLC's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.17 – $0.17) across 2 analysts. Full-year EPS is projected at $0.73, rising to $0.74 the following year.
How much revenue is CLARIVATE PLC expected to report next quarter?+
Consensus revenue is $496.4M (range $496.4M – $496.4M). Full-year revenue is projected at $2.2B, growing to $2.0B next year.
Have analysts been upgrading or downgrading CLVT lately?+
As of Jul, 0 of 6 firms rate CLVT a Buy (4 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLVT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
